Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

38.56
+0.21000.55%
Post-market: 38.560.00000.00%16:10 EST
Volume:813.35K
Turnover:31.52M
Market Cap:4.37B
PE:-19.76
High:39.70
Open:38.34
Low:37.77
Close:38.35
52wk High:41.47
52wk Low:14.06
Shares:113.39M
Float Shares:64.72M
Volume Ratio:0.62
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9515
EPS(LYR):-2.5604
ROE:-39.94%
ROA:-20.70%
PB:6.01
PE(LYR):-15.06

Loading ...

Stock Track | NewAmsterdam Pharma (NAMS) Soars 5% as Analysts Maintain Buy Ratings with High Price Targets

Stock Track
·
Nov 10

RBC Capital Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS)

TIPRANKS
·
Nov 10

NewAmsterdam Pharma Grants Inducement Share Options to New Hire

Reuters
·
Nov 08

RBC Capital Remains a Buy on NewAmsterdam Pharma Company (NAMS)

TIPRANKS
·
Nov 07

RBC Raises Price Target on NewAmsterdam Pharma to $44 From $39, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Nov 06

NewAmsterdam Pharma Company Nv : Needham Raises Target Price to $46 From $40

THOMSON REUTERS
·
Nov 06

NewAmsterdam Pharma Is Maintained at Buy by Needham

Dow Jones
·
Nov 06

NewAmsterdam Pharma Company Nv : Piper Sandler Raises Target Price to $60 From $37

THOMSON REUTERS
·
Nov 05

NewAmsterdam Pharma Company NV reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 05

NewAmsterdam Pharma reports Q3 revenue of $0.3 million and cash position of $756 million

Reuters
·
Nov 05

Press Release: NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results

Dow Jones
·
Nov 05

NewAmsterdam Pharma Unveils Phase 3 Obicetrapib Data at AHA 2025 Sessions

Reuters
·
Oct 30

NewAmsterdam Pharma’s REMBRANDT Trial: A Potential Game-Changer in Cardiovascular Treatment

TIPRANKS
·
Oct 28

Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women

GlobeNewswire
·
Oct 23

NewAmsterdam Pharma Coverage Assumed by HC Wainwright & Co. at Buy

Dow Jones
·
Oct 20

NewAmsterdam Pharma assumed with a Buy at H.C. Wainwright

TIPRANKS
·
Oct 20

NewAmsterdam Pharma Company (NAMS) Gets a Hold from Goldman Sachs

TIPRANKS
·
Oct 18

NewAmsterdam Pharma Is Maintained at Buy by Citigroup

Dow Jones
·
Oct 17

Could Caristo Collaboration Reveal NewAmsterdam Pharma’s (NAMS) Real Edge in Cardiovascular Innovation?

Simply Wall St.
·
Oct 17

NewAmsterdam Pharma price target raised to $50 from $42 at Citi

TIPRANKS
·
Oct 17